Edwards Lifesciences (EW)

$86.50 0.69 (0.80%)

19:00 EDT EW Stock Quote Delayed 30 Minutes

EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

7 Stocks to Buy at the ‘Midterm Elections’ Bottom

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Volume:

Previous Close -

Market Cap 52.11B

PE Ratio 37.28

EPS 2.32

Volume (Avg. Vol.) 2.43M

Day's Range $85.75 - $87.50

52-Week Range $60.57 - $95.73

Dividend & Yield N/A (N/A)

EW Stock Predictions, Articles, and Edwards Lifesciences News

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 29, 2022

Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about!

7 Growth Stocks That Analysts Love Right Now

By Chris Markoch, InvestorPlace Contributor May 17, 2022

These growth stocks are receiving buy ratings and significantly higher price targets from analysts, making them ideal names to consider.

7 Medical Device Stocks to Buy as Covid-19 Fears Fade

By Josh Enomoto, InvestorPlace Contributor Apr 5, 2022

With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks.

4 Top Stock Trades for Tuesday: NIO, FB, EW, TXN

By Bret Kenwell, InvestorPlace Contributor Jun 28, 2021

Nio, Facebook, Edward Lifesciences and Texas Instruments were our top stock trades for Tuesday. Let's look at how the charts are setting up.

7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul

By Tezcan Gecgil, InvestorPlace Contributor Nov 30, 2020

ESG investing can help create value both for society and shareholders. These seven ESG stocks are a good place to start.

3 Beautiful Breakout Stocks to Buy

By Tyler Craig, Tales of a Technician Aug 19, 2019

All three of these breakthrough stocks to buy boast strong trends and earnings growth that continues unabated.

Collect Income on This Medical Device Company in May

By John Jagerson and Wade Hansen May 20, 2019

We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.

7 Healthcare Stocks That Are Coming to Life

By Anthony Mirhaydari, InvestorPlace Market Strategist Jul 23, 2018

These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.

3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)

By Karl Utermohlen, InvestorPlace Writer Apr 25, 2018

Edwards Lifesciences (EW) and Illumina (ILMN) reported their quarterly earnings results, while Tesla (TSLA) is being accused of stiffing its workers of overtime.

7 Rock-Solid Stocks to Hold On for Dear Life

By Harriet Lefton, Writer, TipRanks Feb 12, 2018

In such fragile market conditions, it pays to keep your portfolio full of solid stocks with consistent growth and a favorable outlook. All of the seven stocks to buy in this article are up on a one-month basis. Some of them by over 10%!

3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW) and Motorola Solutions Inc (MSI)

By Karl Utermohlen, InvestorPlace Writer Feb 2, 2018

Amgen (AMGN) posted underwhelming earnings, Edwards Lifesciences (EW) posts strong 2017 revenue and Motorola Solutions (MSI) expects 2018 EPS to beat estimates.

The 10 Most Expensive Stocks In The S&P 500

By Matt Hogan, Founder, Finbox.io Jan 24, 2018

These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.

Edwards Lifesciences (EW) Ranking Raised to Buy on Robust Earnings Growth

By Portfolio Grader Dec 12, 2017

Edwards Lifesciences (NYSE:EW) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.

Edwards Lifesciences (EW) Upgraded to Buy on Improving Sales Growth

By Portfolio Grader Dec 5, 2017

Portfolio Grader currently ranks Edwards Lifesciences (NYSE:EW) a Buy. The approach to fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. EW has been upgraded from a Hold to a Buy in the last week.

Industry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to Hold

By Portfolio Grader Nov 7, 2017

With a $21.7 billion market value, Edwards Lifesciences (NYSE:EW) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for EW by Portfolio Grader places it 76 among the 164 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 366 among the 785 companies in the sector, and number 2,386 in the nearly 5,000 company Portfolio Grader universe.